Discover the detailed record of transactions filed by Wadlinger Mary E., 管理人员. Director active across 1 company, notably Forma Therapeutics Holdings, Inc.. In total, 1 disclosures have been recorded. Split: 0 buy · 1 sell. Total volume traded: €40k. History available since 23 February 2022. The latest transaction was disclosed on 23 February 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Mary E. Wadlinger is an Executive at Forma Therapeutics Holdings, Inc. She plays a role in the management and strategy of the company, contributing to its development and growth. Her expertise is important for Forma Therapeutics' success.